Acumen completes enrollment of ALTITUDE-AD Phase 2 trial
Pharmaceuticals announced the completion of enrollment in its ALTITUDE-AD Phase 2 trial of sabirnetug in patients with early ...
Alzamend Neuro announces initiation date of Phase II trial of AL001
Alzamend Neuro (ALZN) announced its plans to initiate a highly anticipated phase II clinical study of AL001 for treatment of patients with ...
Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment
Porosome Therapeutics, Inc. (Porosome Therapeutics) today announced its latest development in identifying the secretory dysfunction responsible for Alzheimer’s Disease along with advancements in ...
psypost.org13d
Semaglutide reduces brain inflammation and improves memory in an Alzheimer’s model
A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of Alzheimer’s disease. Researchers found that semaglutide reduced ...
Hosted on MSN18d
Earth The Planet
The film "Earth The Planet" explores the fragile nature of Earth as seen from space and emphasizes the significance of studying its atmosphere and magnetosphere. It discusses how solar emissions ...